BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37831911)

  • 1. Does reduced cathepsin activity contribute to skin and lung fibrosis in patients with systemic sclerosis and related disorders?
    Garton M; Kelly C
    Rheumatology (Oxford); 2024 Mar; 63(3):e81-e82. PubMed ID: 37831911
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic sclerosis sine scleroderma presenting with vitiligo-like depigmentation and interstitial pulmonary fibrosis.
    De Villiers WJ; Jordaan HF; Bates W
    Clin Exp Dermatol; 1992 Mar; 17(2):127-31. PubMed ID: 1516238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediastinal lymphadenopathy preceding skin and lung fibrosis in systemic sclerosis.
    Yoshioka K
    Respiration; 1994; 61(3):169-71. PubMed ID: 8047722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis sine scleroderma presenting as pulmonary intersticial fibrosis.
    Vañó Sanchis D; Arranz Garcia G; Yglesias PJ
    Clin Rheumatol; 2006 May; 25(3):382-3. PubMed ID: 16211337
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis.
    Lomeo RM; Cornella RJ; Schabel SI; Silver RM
    Am J Med; 1989 Nov; 87(5):525-7. PubMed ID: 2683765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CT of the lung fibrosis in progressive systemic sclerosis].
    Koba H; Kato S; Watanabe H; Mori Y; Sizyubo N; Tanaka H; Yamagishi M; Mori M; Suzuki A
    Rinsho Hoshasen; 1989 Jan; 34(1):107-13. PubMed ID: 2724590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral pulmonary fibrosis and systemic sclerosis.
    Lesnyak VN; Danilevskaya OV; Averyanov AV; Ananyeva LP
    Am J Respir Crit Care Med; 2014 Nov; 190(9):1067-8. PubMed ID: 25360729
    [No Abstract]   [Full Text] [Related]  

  • 8. Lung involvement in systemic sclerosis sine scleroderma treated by plasma exchange.
    Ferri C; Bernini L; Gremignai G; Latorraca A; Fazzi P; Tavon A; Solfanelli S; Bombardieri S
    Int J Artif Organs; 1992 Jul; 15(7):426-31. PubMed ID: 1516994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary fibrosis in scleroderma: report of a case with pulmonary function studies to evaluate corticosteroid and relaxin therapy.
    TRANQUADA RE; SIMMONS DH; MILLER JH
    Arch Intern Med; 1960 Apr; 105():607-12. PubMed ID: 13839183
    [No Abstract]   [Full Text] [Related]  

  • 10. D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).
    Medsger TA
    Arthritis Rheum; 1987 Jul; 30(7):832-4. PubMed ID: 3304300
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid onset of lung involvement in progressive systemic sclerosis.
    Bettmann MA; Kantrowitz F
    Chest; 1979 Apr; 75(4):509-10. PubMed ID: 446143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lung in systemic sclerosis.
    Steen VD
    J Clin Rheumatol; 2005 Feb; 11(1):40-6. PubMed ID: 16357695
    [No Abstract]   [Full Text] [Related]  

  • 13. Case report. Progressive systemic sclerosis presenting as interstitial pulmonary fibrosis.
    Olson DS; Kumar UN; Funahashi A
    Postgrad Med; 1978 Jul; 64(1):173-5. PubMed ID: 673967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of end stage lung disease in systemic sclerosis.
    Steen V
    Ann Rheum Dis; 2003 Feb; 62(2):97-9. PubMed ID: 12525376
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary involvement in progressive systemic sclerosis].
    Yoshimura K; Nakatani T; Chonabayashi N; Nakamori Y; Nakata K; Tanimoto H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Dec; 24(12):1345-53. PubMed ID: 3573451
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating new therapies for systemic sclerosis-associated lung fibrosis in clinical practice.
    Khanna D; Denton CP
    Lancet Respir Med; 2021 Jun; 9(6):560-562. PubMed ID: 34015325
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interstitial lung disease in systemic lupus erythematosus, progressive systemic sclerosis and dermatomyositis].
    Tokano Y; Hashimoto H; Hirose S
    Nihon Rinsho; 1990 Mar; 48(3):530-4. PubMed ID: 2355486
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis.
    Briggs DC; Vaughan RW; Welsh KI; Myers A; duBois RM; Black CM
    Lancet; 1991 Sep; 338(8768):661-2. PubMed ID: 1679476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m MIBI uptake secondary to pulmonary interstitial fibrosis in progressive systemic sclerosis.
    Richard MD; Park CH
    Clin Nucl Med; 1995 Mar; 20(3):256-8. PubMed ID: 7750221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung involvement in systemic sclerosis.
    Silver RM; Miller KS
    Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.